TY - JOUR
T1 - Sleep disturbances and cognitive impairment in the course of type 2 diabetes-a possible link
AU - Brzecka, Anna
AU - Madetko, Natalia
AU - Nikolenko, Vladimir N.
AU - Ashraf, Ghulam M.
AU - Ejma, Maria
AU - Leszek, Jerzy
AU - Daroszewski, Cyryl
AU - Sarul, Karolina
AU - Mikhaleva, Liudmila M.
AU - Somasundaram, Siva G.
AU - Kirkland, Cecil E.
AU - Bachurin, Sergey O.
AU - Aliev, Gjumrakch
N1 - Publisher Copyright:
©2021 Bentham Science Publishers.
PY - 2021
Y1 - 2021
N2 - There is an increasing number of patients worldwide with sleep disturbances and diabetes. Various sleep disorders, including long or short sleep duration and poor sleep quality of numer-ous causes, may increase the risk of diabetes. Some symptoms of diabetes, such as painful peripheral neuropathy and nocturia, or associated other sleep disorders, such as sleep breathing disorders or sleep movement disorders, may influence sleep quality and quantity. Both sleep disorders and diabetes may lead to cognitive impairment. The risk of development of cognitive impairment in diabetic patients may be related to vascular and non-vascular and other factors, such as hypoglyce-mia, hyperglycemia, central insulin resistance, amyloid and tau deposits and other causes. Numer-ous sleep disorders, e.g., sleep apnea, restless legs syndrome, insomnia, and poor sleep quality are most likely are also associated with cognitive impairment. Adequate functioning of the system of clearance of the brain from toxic substances, such as amyloid β, i.e. glymphatic system, is related to undisturbed sleep and prevents cognitive impairment. In the case of coexistence, sleep disturbances and diabetes either independently lead to and/or mutually aggravate cognitive impairment.
AB - There is an increasing number of patients worldwide with sleep disturbances and diabetes. Various sleep disorders, including long or short sleep duration and poor sleep quality of numer-ous causes, may increase the risk of diabetes. Some symptoms of diabetes, such as painful peripheral neuropathy and nocturia, or associated other sleep disorders, such as sleep breathing disorders or sleep movement disorders, may influence sleep quality and quantity. Both sleep disorders and diabetes may lead to cognitive impairment. The risk of development of cognitive impairment in diabetic patients may be related to vascular and non-vascular and other factors, such as hypoglyce-mia, hyperglycemia, central insulin resistance, amyloid and tau deposits and other causes. Numer-ous sleep disorders, e.g., sleep apnea, restless legs syndrome, insomnia, and poor sleep quality are most likely are also associated with cognitive impairment. Adequate functioning of the system of clearance of the brain from toxic substances, such as amyloid β, i.e. glymphatic system, is related to undisturbed sleep and prevents cognitive impairment. In the case of coexistence, sleep disturbances and diabetes either independently lead to and/or mutually aggravate cognitive impairment.
KW - Central nervous system
KW - Dementia
KW - Glymphatic system
KW - Hyperglycemia
KW - Hypoglycemia
KW - Insulin
KW - Risk factors
KW - Sleep apnea
UR - http://www.scopus.com/inward/record.url?scp=85099721603&partnerID=8YFLogxK
U2 - 10.2174/1570159X18666200309101750
DO - 10.2174/1570159X18666200309101750
M3 - Review article
C2 - 32148197
AN - SCOPUS:85099721603
SN - 1570-159X
VL - 19
SP - 78
EP - 91
JO - Current Neuropharmacology
JF - Current Neuropharmacology
IS - 1
ER -